Genome-wide association studies (GWAS) do not support CD22 as disease susceptibility locus in SLE or other autoimmune diseases; however it seems that polymorphisms in CD22 are relatively rare and variable between populations. This evidence concerns the gene CD22 and autoimmune disease.